

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.20667874 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.18871936 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.17024203 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.17024203 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.12293895 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12293895 |
| 7 | mannosylation (GO:0097502) | 4.09850248 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.98331820 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98331820 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95308355 |
| 11 | chaperone-mediated protein transport (GO:0072321) | 3.88426970 |
| 12 | behavioral response to nicotine (GO:0035095) | 3.85598470 |
| 13 | platelet dense granule organization (GO:0060155) | 3.81826440 |
| 14 | positive regulation of prostaglandin secretion (GO:0032308) | 3.73080645 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.71843516 |
| 16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.71843516 |
| 17 | NADH dehydrogenase complex assembly (GO:0010257) | 3.71843516 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71781721 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 3.71781721 |
| 20 | protein complex biogenesis (GO:0070271) | 3.69015054 |
| 21 | sequestering of actin monomers (GO:0042989) | 3.68072773 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 3.65648269 |
| 23 | negative regulation of sterol transport (GO:0032372) | 3.65648269 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.60918943 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.60832084 |
| 26 | ubiquinone biosynthetic process (GO:0006744) | 3.58521685 |
| 27 | kynurenine metabolic process (GO:0070189) | 3.50952107 |
| 28 | glycine metabolic process (GO:0006544) | 3.44372942 |
| 29 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.44221343 |
| 30 | cysteine metabolic process (GO:0006534) | 3.43450876 |
| 31 | regulation of cholesterol homeostasis (GO:2000188) | 3.43241167 |
| 32 | aromatic amino acid family catabolic process (GO:0009074) | 3.42110363 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 3.40682906 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.40252004 |
| 35 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.39877532 |
| 36 | negative regulation of telomere maintenance (GO:0032205) | 3.37076210 |
| 37 | urea cycle (GO:0000050) | 3.35527619 |
| 38 | urea metabolic process (GO:0019627) | 3.35527619 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34797808 |
| 40 | protein neddylation (GO:0045116) | 3.34650752 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.33737512 |
| 42 | protein carboxylation (GO:0018214) | 3.33737512 |
| 43 | ubiquinone metabolic process (GO:0006743) | 3.32812705 |
| 44 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.30896068 |
| 45 | epithelial cilium movement (GO:0003351) | 3.30762206 |
| 46 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.30507037 |
| 47 | electron transport chain (GO:0022900) | 3.26321769 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.24936650 |
| 49 | respiratory electron transport chain (GO:0022904) | 3.24397634 |
| 50 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.24104814 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 3.22215889 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.18176833 |
| 53 | indole-containing compound catabolic process (GO:0042436) | 3.18176833 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 3.18176833 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.16531118 |
| 56 | amine catabolic process (GO:0009310) | 3.16531118 |
| 57 | regulation of triglyceride catabolic process (GO:0010896) | 3.13972001 |
| 58 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.13710321 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12817144 |
| 60 | pentose-phosphate shunt (GO:0006098) | 3.09370745 |
| 61 | lysine metabolic process (GO:0006553) | 3.08967789 |
| 62 | lysine catabolic process (GO:0006554) | 3.08967789 |
| 63 | serine family amino acid biosynthetic process (GO:0009070) | 3.08959994 |
| 64 | protein-cofactor linkage (GO:0018065) | 3.05905372 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 3.05584936 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 3.05360401 |
| 67 | phospholipid efflux (GO:0033700) | 3.00508582 |
| 68 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.98370415 |
| 69 | regulation of prostaglandin secretion (GO:0032306) | 2.97970930 |
| 70 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.95989106 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 2.94676093 |
| 72 | tryptophan metabolic process (GO:0006568) | 2.94545728 |
| 73 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.94435562 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.94435562 |
| 75 | positive regulation of T cell apoptotic process (GO:0070234) | 2.93733262 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 2.91588902 |
| 77 | serine family amino acid catabolic process (GO:0009071) | 2.91268458 |
| 78 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.89131987 |
| 79 | protein-lipid complex assembly (GO:0065005) | 2.88702179 |
| 80 | positive regulation of icosanoid secretion (GO:0032305) | 2.88512215 |
| 81 | proteasome assembly (GO:0043248) | 2.88041801 |
| 82 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.87579906 |
| 83 | respiratory chain complex IV assembly (GO:0008535) | 2.86289364 |
| 84 | quinone biosynthetic process (GO:1901663) | 2.85936837 |
| 85 | proline biosynthetic process (GO:0006561) | 2.85557507 |
| 86 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.84144582 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82834756 |
| 88 | complement activation, alternative pathway (GO:0006957) | 2.82632495 |
| 89 | metallo-sulfur cluster assembly (GO:0031163) | 2.82479650 |
| 90 | iron-sulfur cluster assembly (GO:0016226) | 2.82479650 |
| 91 | positive regulation of histone deacetylation (GO:0031065) | 2.82004292 |
| 92 | bile acid biosynthetic process (GO:0006699) | 2.82002871 |
| 93 | hydrogen ion transmembrane transport (GO:1902600) | 2.81371344 |
| 94 | cytochrome complex assembly (GO:0017004) | 2.80383712 |
| 95 | maternal placenta development (GO:0001893) | 2.80020354 |
| 96 | positive regulation of fatty acid transport (GO:2000193) | 2.79789340 |
| 97 | ethanol oxidation (GO:0006069) | 2.79269911 |
| 98 | viral transcription (GO:0019083) | 2.78833617 |
| 99 | intestinal cholesterol absorption (GO:0030299) | 2.77094173 |
| 100 | indolalkylamine metabolic process (GO:0006586) | 2.76115634 |
| 101 | negative regulation of interleukin-1 production (GO:0032692) | 2.75347105 |
| 102 | regulation of fibrinolysis (GO:0051917) | 2.75246886 |
| 103 | intracellular protein transmembrane import (GO:0044743) | 2.73455175 |
| 104 | homocysteine metabolic process (GO:0050667) | 2.73000985 |
| 105 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72311051 |
| 106 | proton transport (GO:0015992) | 2.71520576 |
| 107 | reverse cholesterol transport (GO:0043691) | 2.69861458 |
| 108 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69140698 |
| 109 | NADPH regeneration (GO:0006740) | 2.69119237 |
| 110 | regulation of cholesterol storage (GO:0010885) | 2.68913833 |
| 111 | amino-acid betaine metabolic process (GO:0006577) | 2.68340682 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 2.67923898 |
| 113 | vitamin biosynthetic process (GO:0009110) | 2.67349505 |
| 114 | deoxyribonucleotide catabolic process (GO:0009264) | 2.67106749 |
| 115 | regulation of chronic inflammatory response (GO:0002676) | 2.66111390 |
| 116 | 4-hydroxyproline metabolic process (GO:0019471) | 2.65795765 |
| 117 | hydrogen transport (GO:0006818) | 2.65475635 |
| 118 | regulation of protein activation cascade (GO:2000257) | 2.65072907 |
| 119 | somite development (GO:0061053) | 2.64575378 |
| 120 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.64138077 |
| 121 | DNA deamination (GO:0045006) | 2.62706823 |
| 122 | positive regulation of organic acid transport (GO:0032892) | 2.62687895 |
| 123 | plasma lipoprotein particle remodeling (GO:0034369) | 2.62619173 |
| 124 | protein-lipid complex remodeling (GO:0034368) | 2.62619173 |
| 125 | macromolecular complex remodeling (GO:0034367) | 2.62619173 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.62081136 |
| 127 | DNA damage response, detection of DNA damage (GO:0042769) | 2.61155186 |
| 128 | proline metabolic process (GO:0006560) | 2.60656342 |
| 129 | L-serine metabolic process (GO:0006563) | 2.60172111 |
| 130 | base-excision repair, AP site formation (GO:0006285) | 2.60164174 |
| 131 | regulation of superoxide anion generation (GO:0032928) | 2.59212735 |
| 132 | translational termination (GO:0006415) | 2.58575580 |
| 133 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.58313197 |
| 134 | cholesterol homeostasis (GO:0042632) | 2.56600788 |
| 135 | regulation of immunoglobulin secretion (GO:0051023) | 2.54072026 |
| 136 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.53822236 |
| 137 | nucleobase catabolic process (GO:0046113) | 2.53678614 |
| 138 | regulation of mononuclear cell migration (GO:0071675) | 2.53504944 |
| 139 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.52707730 |
| 140 | cellular modified amino acid catabolic process (GO:0042219) | 2.52546404 |
| 141 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.52014680 |
| 142 | bile acid metabolic process (GO:0008206) | 2.51408438 |
| 143 | quinone metabolic process (GO:1901661) | 2.50934033 |
| 144 | cellular response to interferon-beta (GO:0035458) | 2.50919373 |
| 145 | sterol homeostasis (GO:0055092) | 2.50825920 |
| 146 | acylglycerol homeostasis (GO:0055090) | 2.49451257 |
| 147 | triglyceride homeostasis (GO:0070328) | 2.49451257 |
| 148 | ethanol metabolic process (GO:0006067) | 2.48583731 |
| 149 | regulation of complement activation (GO:0030449) | 2.47864358 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47749256 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.47610026 |
| 152 | regulation of triglyceride metabolic process (GO:0090207) | 2.47386508 |
| 153 | arginine catabolic process (GO:0006527) | 2.46185725 |
| 154 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.45820709 |
| 155 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.45820709 |
| 156 | primary alcohol catabolic process (GO:0034310) | 2.45203437 |
| 157 | positive regulation of calcium ion import (GO:0090280) | 2.44459416 |
| 158 | aromatic amino acid family metabolic process (GO:0009072) | 2.44456364 |
| 159 | GTP biosynthetic process (GO:0006183) | 2.43967799 |
| 160 | positive regulation of lipid catabolic process (GO:0050996) | 2.43618827 |
| 161 | cholesterol efflux (GO:0033344) | 2.43038247 |
| 162 | piRNA metabolic process (GO:0034587) | 2.41554130 |
| 163 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41363154 |
| 164 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.41275808 |
| 165 | translational elongation (GO:0006414) | 2.40710671 |
| 166 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.40654203 |
| 167 | ATP biosynthetic process (GO:0006754) | 2.40425706 |
| 168 | L-fucose catabolic process (GO:0042355) | 2.40245232 |
| 169 | fucose catabolic process (GO:0019317) | 2.40245232 |
| 170 | L-fucose metabolic process (GO:0042354) | 2.40245232 |
| 171 | aldehyde catabolic process (GO:0046185) | 2.38893149 |
| 172 | valine metabolic process (GO:0006573) | 2.38276384 |
| 173 | termination of RNA polymerase III transcription (GO:0006386) | 2.38012511 |
| 174 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.38012511 |
| 175 | positive regulation of amino acid transport (GO:0051957) | 2.37985809 |
| 176 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.37702772 |
| 177 | one-carbon metabolic process (GO:0006730) | 2.37357973 |
| 178 | deoxyribose phosphate catabolic process (GO:0046386) | 2.37265224 |
| 179 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.37196349 |
| 180 | alpha-amino acid catabolic process (GO:1901606) | 2.36371729 |
| 181 | cilium movement (GO:0003341) | 2.36283835 |
| 182 | protein polyglutamylation (GO:0018095) | 2.36100516 |
| 183 | negative regulation of lipid transport (GO:0032369) | 2.35411873 |
| 184 | plasma lipoprotein particle organization (GO:0071827) | 2.35324429 |
| 185 | mitochondrial calcium ion transport (GO:0006851) | 2.32442066 |
| 186 | intraciliary transport (GO:0042073) | 2.30235726 |
| 187 | negative regulation of mast cell activation (GO:0033004) | 2.29749692 |
| 188 | anterograde synaptic vesicle transport (GO:0048490) | 2.27527774 |
| 189 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.27149835 |
| 190 | positive regulation of defense response to virus by host (GO:0002230) | 2.25937647 |
| 191 | C-terminal protein lipidation (GO:0006501) | 2.24159908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.48339010 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.45914482 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.99794929 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.67053697 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.56237135 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.37133708 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.17170492 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.15523605 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11674026 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.78428670 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.73248709 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.69700952 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.60613702 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53333821 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.48569272 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.47865318 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.21400893 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.17401740 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14648688 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.09490523 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06050245 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.01374081 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.99915092 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96596585 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91011193 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82312305 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.81762661 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80100995 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75575885 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.75358842 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72643980 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72510053 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72433586 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.72072845 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69530604 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69325008 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69195185 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68263883 |
| 39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64163229 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63671086 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60398444 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59179069 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59021238 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58839442 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57122711 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55756972 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52528659 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50499075 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50378290 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49888826 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47867843 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47607989 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46735227 |
| 54 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.45346331 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45172055 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44763592 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44710773 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44194749 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43676422 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.43647157 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.43561980 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43442891 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42534971 |
| 64 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.41637651 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41361615 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41010572 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40982360 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37194463 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36580684 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36452045 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.35879446 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.35821887 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33938685 |
| 74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33041291 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32936224 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32445610 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.31948646 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31096206 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30328087 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30301614 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30252802 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29768595 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28336528 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28250204 |
| 85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27842827 |
| 86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26369238 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.25961990 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25817012 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25434821 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23990621 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23990621 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23183123 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.23130639 |
| 94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22575626 |
| 95 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.22417024 |
| 96 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.22151802 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21548891 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.20921303 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20899771 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20807567 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20332249 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18818535 |
| 103 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18797312 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18671657 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18332024 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18070994 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.18021495 |
| 108 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17076022 |
| 109 | ERA_21632823_ChIP-Seq_H3396_Human | 1.17020519 |
| 110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14740694 |
| 111 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14539728 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13784272 |
| 113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13384958 |
| 114 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11633209 |
| 115 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11492499 |
| 116 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.11355699 |
| 117 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10299386 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10028068 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09596273 |
| 120 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09504185 |
| 121 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09454581 |
| 122 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09454581 |
| 123 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09192379 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09061247 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08645537 |
| 126 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.08371833 |
| 127 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07544592 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07488521 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 1.07266722 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07250708 |
| 131 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07186136 |
| 132 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07096739 |
| 133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06776786 |
| 134 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06093999 |
| 135 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05520067 |
| 136 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05268828 |
| 137 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04833295 |
| 138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03838402 |
| 139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03838402 |
| 140 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03665682 |
| 141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03556312 |
| 142 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03232377 |
| 143 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02880409 |
| 144 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02235863 |
| 145 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00668657 |
| 146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00067835 |
| 147 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99980953 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98981267 |
| 149 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98864449 |
| 150 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98495191 |
| 151 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98064026 |
| 152 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97919236 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97523051 |
| 154 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97338967 |
| 155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97212457 |
| 156 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97158551 |
| 157 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96984068 |
| 158 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96738847 |
| 159 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96698663 |
| 160 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96645265 |
| 161 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96581236 |
| 162 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96524286 |
| 163 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96342570 |
| 164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95728905 |
| 165 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95609055 |
| 166 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95479583 |
| 167 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94747396 |
| 168 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94104253 |
| 169 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93372454 |
| 170 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92554688 |
| 171 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92541079 |
| 172 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.92306638 |
| 173 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.91812101 |
| 174 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89097552 |
| 175 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89060082 |
| 176 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89032233 |
| 177 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88647441 |
| 178 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88414054 |
| 179 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85890838 |
| 180 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85055954 |
| 181 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84514461 |
| 182 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83927345 |
| 183 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83797642 |
| 184 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.83272995 |
| 185 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82764526 |
| 186 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81518504 |
| 187 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80823787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.14930680 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.05978616 |
| 3 | MP0009840_abnormal_foam_cell | 3.48882919 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.27990578 |
| 5 | MP0005365_abnormal_bile_salt | 2.92399882 |
| 6 | MP0002653_abnormal_ependyma_morphology | 2.92126555 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.68462910 |
| 8 | MP0003136_yellow_coat_color | 2.64585798 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.64383134 |
| 10 | MP0005083_abnormal_biliary_tract | 2.45411227 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.34029867 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16089924 |
| 13 | MP0000685_abnormal_immune_system | 2.15838975 |
| 14 | MP0004133_heterotaxia | 2.10829255 |
| 15 | MP0003436_decreased_susceptibility_to | 2.10214134 |
| 16 | MP0004142_abnormal_muscle_tone | 2.04657326 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.04314998 |
| 18 | MP0009764_decreased_sensitivity_to | 1.96403396 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.92988260 |
| 20 | MP0003303_peritoneal_inflammation | 1.91819847 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.83510606 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.83233169 |
| 23 | MP0000609_abnormal_liver_physiology | 1.76320954 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.69290692 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.68011779 |
| 26 | MP0001529_abnormal_vocalization | 1.67597561 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.66235833 |
| 28 | MP0004147_increased_porphyrin_level | 1.64145791 |
| 29 | MP0002102_abnormal_ear_morphology | 1.62869722 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.62611271 |
| 31 | MP0003252_abnormal_bile_duct | 1.62177714 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.60896980 |
| 33 | MP0003122_maternal_imprinting | 1.59645619 |
| 34 | MP0009278_abnormal_bone_marrow | 1.58568905 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.58014961 |
| 36 | MP0002163_abnormal_gland_morphology | 1.57378822 |
| 37 | MP0001800_abnormal_humoral_immune | 1.57262684 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.56558351 |
| 39 | MP0003121_genomic_imprinting | 1.56171927 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.55484400 |
| 41 | MP0003787_abnormal_imprinting | 1.53025905 |
| 42 | MP0002938_white_spotting | 1.52284395 |
| 43 | MP0005451_abnormal_body_composition | 1.51119720 |
| 44 | MP0004947_skin_inflammation | 1.49650346 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.49222410 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.48155054 |
| 47 | MP0005387_immune_system_phenotype | 1.47769312 |
| 48 | MP0001790_abnormal_immune_system | 1.47769312 |
| 49 | MP0004742_abnormal_vestibular_system | 1.46999081 |
| 50 | MP0001542_abnormal_bone_strength | 1.46437468 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.44044078 |
| 52 | MP0001293_anophthalmia | 1.41425322 |
| 53 | MP0005025_abnormal_response_to | 1.41158999 |
| 54 | MP0005332_abnormal_amino_acid | 1.40851440 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.38901501 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.38880165 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.38653293 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.38164831 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.38164831 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.34659058 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.32976764 |
| 62 | MP0001919_abnormal_reproductive_system | 1.32957267 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.32777229 |
| 64 | MP0002736_abnormal_nociception_after | 1.32097097 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.30170668 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.29701560 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.28557519 |
| 68 | MP0000343_altered_response_to | 1.26713568 |
| 69 | MP0002723_abnormal_immune_serum | 1.26585099 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.26489232 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.26082960 |
| 72 | MP0005253_abnormal_eye_physiology | 1.25634553 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.25494588 |
| 74 | MP0003646_muscle_fatigue | 1.23894511 |
| 75 | MP0001324_abnormal_eye_pigmentation | 1.23438452 |
| 76 | MP0008469_abnormal_protein_level | 1.23287324 |
| 77 | MP0002405_respiratory_system_inflammati | 1.22779749 |
| 78 | MP0002398_abnormal_bone_marrow | 1.22692548 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.21434160 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.21292721 |
| 81 | MP0002722_abnormal_immune_system | 1.19566437 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.18074660 |
| 83 | MP0009785_altered_susceptibility_to | 1.18032369 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.17422140 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.17294853 |
| 86 | MP0002419_abnormal_innate_immunity | 1.17250232 |
| 87 | MP0000598_abnormal_liver_morphology | 1.15932929 |
| 88 | MP0001853_heart_inflammation | 1.15897520 |
| 89 | MP0000049_abnormal_middle_ear | 1.15888078 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.15200290 |
| 91 | MP0001819_abnormal_immune_cell | 1.14157626 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.13392748 |
| 93 | MP0006082_CNS_inflammation | 1.12527928 |
| 94 | MP0000490_abnormal_crypts_of | 1.10465482 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 1.09500112 |
| 96 | MP0003718_maternal_effect | 1.08510403 |
| 97 | MP0002282_abnormal_trachea_morphology | 1.08351799 |
| 98 | MP0000716_abnormal_immune_system | 1.08149905 |
| 99 | MP0001984_abnormal_olfaction | 1.07058923 |
| 100 | MP0001873_stomach_inflammation | 1.06200458 |
| 101 | MP0002429_abnormal_blood_cell | 1.05662160 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 1.04592546 |
| 103 | MP0003566_abnormal_cell_adhesion | 1.03304202 |
| 104 | MP0002396_abnormal_hematopoietic_system | 1.01681802 |
| 105 | MP0005257_abnormal_intraocular_pressure | 1.01438280 |
| 106 | MP0002254_reproductive_system_inflammat | 0.99910988 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.99854411 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.99106310 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.98942992 |
| 110 | MP0000026_abnormal_inner_ear | 0.98498371 |
| 111 | MP0000778_abnormal_nervous_system | 0.97555064 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.95946776 |
| 113 | MP0005023_abnormal_wound_healing | 0.95854386 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.95686826 |
| 115 | MP0005670_abnormal_white_adipose | 0.95410981 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.95296353 |
| 117 | MP0005410_abnormal_fertilization | 0.95280423 |
| 118 | MP0002132_abnormal_respiratory_system | 0.93500190 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.93085661 |
| 120 | MP0010030_abnormal_orbit_morphology | 0.93015713 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.92895305 |
| 122 | MP0008872_abnormal_physiological_respon | 0.92801173 |
| 123 | MP0005499_abnormal_olfactory_system | 0.92794851 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.92794851 |
| 125 | MP0003724_increased_susceptibility_to | 0.92662322 |
| 126 | MP0006054_spinal_hemorrhage | 0.92628323 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.92318310 |
| 128 | MP0009763_increased_sensitivity_to | 0.91597008 |
| 129 | MP0001905_abnormal_dopamine_level | 0.91225183 |
| 130 | MP0005377_hearing/vestibular/ear_phenot | 0.91062542 |
| 131 | MP0003878_abnormal_ear_physiology | 0.91062542 |
| 132 | MP0005195_abnormal_posterior_eye | 0.90853816 |
| 133 | MP0003693_abnormal_embryo_hatching | 0.90671990 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.90262452 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90172950 |
| 136 | MP0000647_abnormal_sebaceous_gland | 0.89977337 |
| 137 | MP0005389_reproductive_system_phenotype | 0.88319922 |
| 138 | MP0005671_abnormal_response_to | 0.88159196 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.87438908 |
| 140 | MP0003011_delayed_dark_adaptation | 0.86929845 |
| 141 | MP0000858_altered_metastatic_potential | 0.86705917 |
| 142 | MP0000703_abnormal_thymus_morphology | 0.85801694 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.85383402 |
| 144 | MP0001533_abnormal_skeleton_physiology | 0.84830995 |
| 145 | MP0003938_abnormal_ear_development | 0.84319391 |
| 146 | MP0009053_abnormal_anal_canal | 0.83579035 |
| 147 | MP0001663_abnormal_digestive_system | 0.83358695 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.83272485 |
| 149 | MP0003866_abnormal_defecation | 0.82752560 |
| 150 | MP0002796_impaired_skin_barrier | 0.81547266 |
| 151 | MP0002060_abnormal_skin_morphology | 0.80964184 |
| 152 | MP0003186_abnormal_redox_activity | 0.80693077 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.80119270 |
| 154 | MP0009931_abnormal_skin_appearance | 0.79811688 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.79602229 |
| 156 | MP0005391_vision/eye_phenotype | 0.79082738 |
| 157 | MP0001243_abnormal_dermal_layer | 0.78327357 |
| 158 | MP0000604_amyloidosis | 0.77899593 |
| 159 | MP0001963_abnormal_hearing_physiology | 0.77212362 |
| 160 | MP0005220_abnormal_exocrine_pancreas | 0.75641096 |
| 161 | MP0002557_abnormal_social/conspecific_i | 0.74923204 |
| 162 | MP0001764_abnormal_homeostasis | 0.74536299 |
| 163 | MP0005636_abnormal_mineral_homeostasis | 0.73662476 |
| 164 | MP0006036_abnormal_mitochondrial_physio | 0.72113595 |
| 165 | MP0004808_abnormal_hematopoietic_stem | 0.71762720 |
| 166 | MP0003195_calcinosis | 0.71740623 |
| 167 | MP0004957_abnormal_blastocyst_morpholog | 0.71592838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22300192 |
| 2 | Xanthomatosis (HP:0000991) | 4.19894280 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.19578171 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.97922140 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.93536103 |
| 6 | Pancreatic cysts (HP:0001737) | 3.73017645 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.65046650 |
| 8 | Abnormality of midbrain morphology (HP:0002418) | 3.58167527 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.58167527 |
| 10 | True hermaphroditism (HP:0010459) | 3.50576686 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.50312274 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.49444780 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.47324601 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.42482935 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.42158624 |
| 16 | Acute encephalopathy (HP:0006846) | 3.41962029 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.40758580 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.40758580 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.40758580 |
| 20 | Polyphagia (HP:0002591) | 3.32639051 |
| 21 | Increased CSF lactate (HP:0002490) | 3.30135636 |
| 22 | Myocardial infarction (HP:0001658) | 3.27410271 |
| 23 | Nasal polyposis (HP:0100582) | 3.24820583 |
| 24 | Hepatic necrosis (HP:0002605) | 3.24239652 |
| 25 | Type II lissencephaly (HP:0007260) | 3.20390123 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 3.14949162 |
| 27 | Lipid accumulation in hepatocytes (HP:0006561) | 3.12738977 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 3.11983978 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 3.09344634 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04436012 |
| 31 | Progressive macrocephaly (HP:0004481) | 3.03810773 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.03447484 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.03293851 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.92671953 |
| 35 | Hyperammonemia (HP:0001987) | 2.84440248 |
| 36 | Increased serum ferritin (HP:0003281) | 2.84058626 |
| 37 | Sclerocornea (HP:0000647) | 2.83962140 |
| 38 | Abnormality of complement system (HP:0005339) | 2.76268748 |
| 39 | Ketosis (HP:0001946) | 2.75238165 |
| 40 | Polycythemia (HP:0001901) | 2.75133941 |
| 41 | Nephronophthisis (HP:0000090) | 2.73558671 |
| 42 | Complement deficiency (HP:0004431) | 2.72986898 |
| 43 | Joint hemorrhage (HP:0005261) | 2.71791242 |
| 44 | Hypolipoproteinemia (HP:0010981) | 2.69347356 |
| 45 | Pustule (HP:0200039) | 2.68384023 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.66444246 |
| 47 | Colitis (HP:0002583) | 2.65775266 |
| 48 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.64555123 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.61657316 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 2.60492571 |
| 51 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.60291334 |
| 52 | Cerebral edema (HP:0002181) | 2.58967630 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58029919 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.56960184 |
| 55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56089470 |
| 56 | Exertional dyspnea (HP:0002875) | 2.55853565 |
| 57 | Abnormal number of erythroid precursors (HP:0012131) | 2.55618798 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54099296 |
| 59 | Microretrognathia (HP:0000308) | 2.50925403 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50650440 |
| 61 | Stomatitis (HP:0010280) | 2.50131201 |
| 62 | Reticulocytosis (HP:0001923) | 2.49917190 |
| 63 | Retinal dysplasia (HP:0007973) | 2.48099889 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46850277 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.42849540 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.42631598 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.42538981 |
| 68 | Hypoalphalipoproteinemia (HP:0003233) | 2.41443091 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.40095847 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.38086319 |
| 71 | Pendular nystagmus (HP:0012043) | 2.37306022 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36653995 |
| 73 | Anencephaly (HP:0002323) | 2.36532587 |
| 74 | Cystic liver disease (HP:0006706) | 2.32344477 |
| 75 | Optic disc pallor (HP:0000543) | 2.31527130 |
| 76 | Abnormal platelet function (HP:0011869) | 2.30240901 |
| 77 | Impaired platelet aggregation (HP:0003540) | 2.30240901 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.29990090 |
| 79 | Recurrent viral infections (HP:0004429) | 2.27934356 |
| 80 | Increased muscle lipid content (HP:0009058) | 2.27858451 |
| 81 | Lactic acidosis (HP:0003128) | 2.27178844 |
| 82 | Hyperglycinuria (HP:0003108) | 2.26252696 |
| 83 | Late onset (HP:0003584) | 2.25750257 |
| 84 | Congenital stationary night blindness (HP:0007642) | 2.25306241 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.24259133 |
| 86 | Chronic hepatic failure (HP:0100626) | 2.23451715 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21588433 |
| 88 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21540086 |
| 89 | Abnormality of the renal medulla (HP:0100957) | 2.21518258 |
| 90 | Abnormal biliary tract physiology (HP:0012439) | 2.20924609 |
| 91 | Bile duct proliferation (HP:0001408) | 2.20924609 |
| 92 | Increased serum lactate (HP:0002151) | 2.19937900 |
| 93 | Peritonitis (HP:0002586) | 2.19665452 |
| 94 | Pachygyria (HP:0001302) | 2.18358624 |
| 95 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.18170499 |
| 96 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.17478594 |
| 97 | Spastic diplegia (HP:0001264) | 2.16953202 |
| 98 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.16606765 |
| 99 | Acanthocytosis (HP:0001927) | 2.15225921 |
| 100 | Abnormality of glycine metabolism (HP:0010895) | 2.14895148 |
| 101 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14895148 |
| 102 | Abnormality of reticulocytes (HP:0004312) | 2.14388441 |
| 103 | Hyperbilirubinemia (HP:0002904) | 2.13868780 |
| 104 | Respiratory failure (HP:0002878) | 2.13832352 |
| 105 | Menorrhagia (HP:0000132) | 2.13620689 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 2.13409766 |
| 107 | Abnormality of the labia minora (HP:0012880) | 2.12753511 |
| 108 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.12742312 |
| 109 | Lissencephaly (HP:0001339) | 2.11743609 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11056929 |
| 111 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10966568 |
| 112 | Urticaria (HP:0001025) | 2.10166615 |
| 113 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08882925 |
| 114 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08882925 |
| 115 | Epistaxis (HP:0000421) | 2.08485892 |
| 116 | Poikilocytosis (HP:0004447) | 2.08070969 |
| 117 | Abnormal platelet volume (HP:0011876) | 2.07969438 |
| 118 | Agitation (HP:0000713) | 2.07697947 |
| 119 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07169439 |
| 120 | Recurrent fungal infections (HP:0002841) | 2.07116513 |
| 121 | Hypoglycemic coma (HP:0001325) | 2.06822281 |
| 122 | Lethargy (HP:0001254) | 2.06471059 |
| 123 | Chronic otitis media (HP:0000389) | 2.05984438 |
| 124 | IgM deficiency (HP:0002850) | 2.05850021 |
| 125 | Esophageal varix (HP:0002040) | 2.05527857 |
| 126 | Gingival bleeding (HP:0000225) | 2.04827628 |
| 127 | Recurrent bronchitis (HP:0002837) | 2.04043509 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 2.03529928 |
| 129 | Glycosuria (HP:0003076) | 2.03529928 |
| 130 | Abnormality of T cell physiology (HP:0011840) | 2.02442840 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 2.02117262 |
| 132 | Abnormality of purine metabolism (HP:0004352) | 2.02014862 |
| 133 | Hyperglycinemia (HP:0002154) | 2.01949021 |
| 134 | Anophthalmia (HP:0000528) | 2.01697145 |
| 135 | Occipital encephalocele (HP:0002085) | 2.01186809 |
| 136 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.00948717 |
| 137 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.00948717 |
| 138 | Malnutrition (HP:0004395) | 2.00150124 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.99437795 |
| 140 | Mesangial abnormality (HP:0001966) | 1.99078860 |
| 141 | Reticulocytopenia (HP:0001896) | 1.98739875 |
| 142 | Ketoacidosis (HP:0001993) | 1.98346266 |
| 143 | Fat malabsorption (HP:0002630) | 1.97760160 |
| 144 | Epidermoid cyst (HP:0200040) | 1.95432203 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.95229834 |
| 146 | Thrombocytosis (HP:0001894) | 1.93857582 |
| 147 | Abnormality of renal resorption (HP:0011038) | 1.93792961 |
| 148 | Methylmalonic aciduria (HP:0012120) | 1.93354725 |
| 149 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92177344 |
| 150 | Vascular calcification (HP:0004934) | 1.92088739 |
| 151 | CNS demyelination (HP:0007305) | 1.90979611 |
| 152 | Cellulitis (HP:0100658) | 1.90394200 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.89997012 |
| 154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88962428 |
| 155 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88659049 |
| 156 | Congenital hepatic fibrosis (HP:0002612) | 1.88536169 |
| 157 | Male pseudohermaphroditism (HP:0000037) | 1.88496892 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.87748120 |
| 159 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86210538 |
| 160 | Panhypogammaglobulinemia (HP:0003139) | 1.85691575 |
| 161 | Generalized aminoaciduria (HP:0002909) | 1.85320252 |
| 162 | Optic neuritis (HP:0100653) | 1.83911510 |
| 163 | Retrobulbar optic neuritis (HP:0100654) | 1.83911510 |
| 164 | Recurrent skin infections (HP:0001581) | 1.83170619 |
| 165 | Hemorrhage of the eye (HP:0011885) | 1.83028599 |
| 166 | Thrombophlebitis (HP:0004418) | 1.82976449 |
| 167 | Petechiae (HP:0000967) | 1.82389908 |
| 168 | Mitral stenosis (HP:0001718) | 1.81658137 |
| 169 | Dicarboxylic aciduria (HP:0003215) | 1.81449144 |
| 170 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81449144 |
| 171 | Keratoconus (HP:0000563) | 1.81189911 |
| 172 | Increased corneal curvature (HP:0100692) | 1.81189911 |
| 173 | Achilles tendon contracture (HP:0001771) | 1.81153003 |
| 174 | Multiple enchondromatosis (HP:0005701) | 1.80602472 |
| 175 | Verrucae (HP:0200043) | 1.78195471 |
| 176 | Papilloma (HP:0012740) | 1.78195471 |
| 177 | Hypertriglyceridemia (HP:0002155) | 1.77934838 |
| 178 | Respiratory difficulties (HP:0002880) | 1.77900350 |
| 179 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77308280 |
| 180 | Glomerulonephritis (HP:0000099) | 1.76425437 |
| 181 | Ulnar bowing (HP:0003031) | 1.75693696 |
| 182 | Abnormality of the renal cortex (HP:0011035) | 1.75622913 |
| 183 | Disproportionate short-trunk short stature (HP:0003521) | 1.72370911 |
| 184 | Mutism (HP:0002300) | 1.72217767 |
| 185 | Cerebellar dysplasia (HP:0007033) | 1.70617264 |
| 186 | Delayed CNS myelination (HP:0002188) | 1.69851050 |
| 187 | Concave nail (HP:0001598) | 1.69817968 |
| 188 | Flat capital femoral epiphysis (HP:0003370) | 1.68779806 |
| 189 | Orchitis (HP:0100796) | 1.68124326 |
| 190 | Tubular atrophy (HP:0000092) | 1.66472208 |
| 191 | Postaxial foot polydactyly (HP:0001830) | 1.65530016 |
| 192 | Oculomotor apraxia (HP:0000657) | 1.64240872 |
| 193 | Congenital primary aphakia (HP:0007707) | 1.62764283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.73104632 |
| 2 | ERN1 | 3.65531626 |
| 3 | MAP3K10 | 3.64906671 |
| 4 | MAP4K1 | 3.50397233 |
| 5 | MAP4K2 | 3.42503771 |
| 6 | ADRBK2 | 3.29158525 |
| 7 | EEF2K | 2.79042106 |
| 8 | PKN2 | 2.64510561 |
| 9 | NME2 | 2.57591708 |
| 10 | VRK2 | 2.38599669 |
| 11 | ZAK | 2.36253719 |
| 12 | BCKDK | 2.33911777 |
| 13 | PINK1 | 2.29809413 |
| 14 | NUAK1 | 2.16345735 |
| 15 | DYRK2 | 2.11962741 |
| 16 | GRK1 | 2.11235450 |
| 17 | GRK6 | 2.01210704 |
| 18 | MAP3K11 | 1.99848313 |
| 19 | GRK7 | 1.99560449 |
| 20 | CDK19 | 1.98590960 |
| 21 | WNK3 | 1.95289161 |
| 22 | TBK1 | 1.94190531 |
| 23 | STK16 | 1.92624695 |
| 24 | CASK | 1.92025744 |
| 25 | SIK1 | 1.86856646 |
| 26 | FGFR4 | 1.86656279 |
| 27 | VRK1 | 1.83701288 |
| 28 | ICK | 1.80804746 |
| 29 | TYK2 | 1.80782194 |
| 30 | STK10 | 1.75517013 |
| 31 | ZAP70 | 1.74518926 |
| 32 | BMPR1B | 1.69027036 |
| 33 | ACVR1B | 1.67929621 |
| 34 | MAP3K3 | 1.63216161 |
| 35 | LIMK1 | 1.56247473 |
| 36 | KDR | 1.54938762 |
| 37 | MAP2K3 | 1.53373117 |
| 38 | NEK2 | 1.53168125 |
| 39 | FRK | 1.50297116 |
| 40 | LRRK2 | 1.45278114 |
| 41 | RPS6KA4 | 1.43252796 |
| 42 | EPHB2 | 1.41268053 |
| 43 | CDK12 | 1.37566590 |
| 44 | PTK6 | 1.36935797 |
| 45 | WNK4 | 1.34439577 |
| 46 | INSRR | 1.33512779 |
| 47 | BLK | 1.29836567 |
| 48 | TNIK | 1.28963518 |
| 49 | TRIM28 | 1.28732795 |
| 50 | PDK2 | 1.25708249 |
| 51 | IKBKE | 1.25144320 |
| 52 | MATK | 1.21836253 |
| 53 | EPHB1 | 1.19720965 |
| 54 | BTK | 1.19675504 |
| 55 | TTN | 1.19143147 |
| 56 | CSK | 1.18773305 |
| 57 | MAP2K2 | 1.17061364 |
| 58 | TAOK3 | 1.15474430 |
| 59 | DYRK3 | 1.15334545 |
| 60 | CSNK1G2 | 1.15291018 |
| 61 | CDK4 | 1.14445032 |
| 62 | CSNK1G3 | 1.13753341 |
| 63 | MAPK11 | 1.13440243 |
| 64 | PIM1 | 1.10430384 |
| 65 | DYRK1B | 1.09144083 |
| 66 | JAK3 | 1.08932601 |
| 67 | FLT3 | 1.07522606 |
| 68 | TESK1 | 1.07086876 |
| 69 | TESK2 | 1.06129293 |
| 70 | PIM2 | 1.06029384 |
| 71 | CSF1R | 0.98767273 |
| 72 | TXK | 0.97673882 |
| 73 | TGFBR1 | 0.96558993 |
| 74 | CSNK1G1 | 0.96330449 |
| 75 | IKBKB | 0.92703522 |
| 76 | TGFBR2 | 0.91591108 |
| 77 | MAP3K8 | 0.91235623 |
| 78 | ADRBK1 | 0.90594315 |
| 79 | PKN1 | 0.86393156 |
| 80 | MAP2K7 | 0.86166983 |
| 81 | CSNK1A1L | 0.84564830 |
| 82 | BCR | 0.84353832 |
| 83 | RPS6KB2 | 0.82699205 |
| 84 | SIK2 | 0.82228674 |
| 85 | MAPK13 | 0.81881067 |
| 86 | KIT | 0.80878847 |
| 87 | BMX | 0.80798158 |
| 88 | CDK6 | 0.79769468 |
| 89 | CHUK | 0.79071777 |
| 90 | MAP3K14 | 0.78005417 |
| 91 | LMTK2 | 0.77779777 |
| 92 | TAOK1 | 0.77604382 |
| 93 | MAPKAPK3 | 0.76100024 |
| 94 | NME1 | 0.74066801 |
| 95 | PAK4 | 0.73808489 |
| 96 | RPS6KA5 | 0.72914557 |
| 97 | JAK2 | 0.72910142 |
| 98 | ITK | 0.72857819 |
| 99 | STK4 | 0.72009781 |
| 100 | CDK7 | 0.70751592 |
| 101 | PRKCG | 0.69910588 |
| 102 | SYK | 0.69478824 |
| 103 | IRAK3 | 0.69467722 |
| 104 | MTOR | 0.68729592 |
| 105 | RIPK1 | 0.68536850 |
| 106 | LCK | 0.67562390 |
| 107 | IRAK1 | 0.63291374 |
| 108 | MST1R | 0.62172119 |
| 109 | TLK1 | 0.61039088 |
| 110 | ARAF | 0.61031303 |
| 111 | HCK | 0.57970331 |
| 112 | MAPK4 | 0.57066281 |
| 113 | PIK3CA | 0.56338798 |
| 114 | SCYL2 | 0.56246746 |
| 115 | PRKCE | 0.55804365 |
| 116 | HIPK2 | 0.55791845 |
| 117 | RPS6KA6 | 0.55620746 |
| 118 | DAPK2 | 0.54911559 |
| 119 | MAP3K7 | 0.54591928 |
| 120 | BUB1 | 0.54312490 |
| 121 | DAPK3 | 0.52748313 |
| 122 | TAOK2 | 0.52475212 |
| 123 | PASK | 0.52449470 |
| 124 | MAP3K4 | 0.51962866 |
| 125 | NLK | 0.51277124 |
| 126 | PAK2 | 0.51039573 |
| 127 | JAK1 | 0.50833126 |
| 128 | CLK1 | 0.49267400 |
| 129 | RPS6KA1 | 0.48479842 |
| 130 | LYN | 0.48190594 |
| 131 | PLK1 | 0.47750023 |
| 132 | PRKACA | 0.47714465 |
| 133 | RPS6KL1 | 0.47497131 |
| 134 | RPS6KC1 | 0.47497131 |
| 135 | ILK | 0.47385335 |
| 136 | MARK3 | 0.47233538 |
| 137 | AURKA | 0.47203229 |
| 138 | MAPKAPK2 | 0.46038197 |
| 139 | PAK3 | 0.45981459 |
| 140 | IRAK4 | 0.45483242 |
| 141 | PRKCQ | 0.44295430 |
| 142 | TEC | 0.43557005 |
| 143 | CSNK2A1 | 0.41885524 |
| 144 | PRKG2 | 0.39289570 |
| 145 | OXSR1 | 0.38665644 |
| 146 | CSNK1A1 | 0.37436284 |
| 147 | PRKCD | 0.37242909 |
| 148 | NTRK2 | 0.36966405 |
| 149 | DDR2 | 0.36912811 |
| 150 | CDC7 | 0.36438688 |
| 151 | CCNB1 | 0.36049836 |
| 152 | MAPK15 | 0.35630978 |
| 153 | TIE1 | 0.33125003 |
| 154 | MAP3K12 | 0.32277452 |
| 155 | PRKD2 | 0.32230302 |
| 156 | MAP2K6 | 0.31914378 |
| 157 | PTK2 | 0.31188712 |
| 158 | PRKCI | 0.31158534 |
| 159 | MARK1 | 0.30656233 |
| 160 | CAMK1D | 0.30487032 |
| 161 | GSK3A | 0.30295197 |
| 162 | MAP3K1 | 0.30135483 |
| 163 | AKT2 | 0.29784966 |
| 164 | EGFR | 0.29045743 |
| 165 | PDK1 | 0.28629393 |
| 166 | PHKG1 | 0.28428351 |
| 167 | PHKG2 | 0.28428351 |
| 168 | EPHA3 | 0.27877342 |
| 169 | ABL2 | 0.27741511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.84913645 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.07799996 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83985377 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50362541 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.31695673 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.30975741 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23144184 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18653368 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10360259 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.08749002 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05051475 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.94490722 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.93627667 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.90931180 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.89915932 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.89046755 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88124990 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87453044 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86462328 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86072489 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.85209917 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84588252 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72953321 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70824402 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.70151618 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69652562 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.67900166 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.67847401 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62517834 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61494812 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.60409833 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58951167 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55531214 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55147285 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54332373 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51726077 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.51067777 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50726724 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49230854 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43831193 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43498285 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.41475844 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.40264528 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38120387 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37195004 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35001200 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32992214 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.31743124 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31372466 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 1.31221058 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31201596 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28698452 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27493263 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 1.24261745 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23823623 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17095503 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13182974 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12155554 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 1.10867389 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08693389 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 1.08186418 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08136665 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05368713 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03603673 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02120731 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01420809 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 1.00038166 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98370590 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98297085 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97503432 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95826527 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94564412 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94321981 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93224229 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92865808 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91987106 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88953995 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88457324 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88431824 |
| 80 | Base excision repair_Homo sapiens_hsa03410 | 0.87920977 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87839914 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86760997 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86171967 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.85248821 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.83924679 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82132720 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80891445 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80381653 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80276639 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80250690 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79343976 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.78875685 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78258290 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75638188 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75266041 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74798454 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74128209 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73030160 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72994647 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.69038195 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67918295 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67394184 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66932367 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66756854 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66339780 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66262144 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66077269 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64590926 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63672174 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62663271 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61493383 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60906964 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59761040 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59647393 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.59115218 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58154866 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.57197828 |
| 118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56615247 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.56470563 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54418285 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51524798 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51245605 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.51137143 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50338770 |
| 125 | Mismatch repair_Homo sapiens_hsa03430 | 0.50313610 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50267373 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50008352 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48744765 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48338054 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.48256737 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.46915479 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46900171 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46235201 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.45661901 |
| 135 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45568298 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45488366 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43778511 |
| 138 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43284365 |
| 139 | Influenza A_Homo sapiens_hsa05164 | 0.42781332 |
| 140 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42271446 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41564661 |
| 142 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41536639 |
| 143 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41124972 |
| 144 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40728611 |
| 145 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39917840 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.39865820 |
| 147 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39799480 |
| 148 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39419705 |
| 149 | Mineral absorption_Homo sapiens_hsa04978 | 0.38723303 |
| 150 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37664150 |

